The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD
- 14 November 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (1) , 977-991
Abstract
Recent studies have shown that the occurrence and progression of nonalcoholic fatty liver disease (NAFLD) can be aggravated by dysregulation of intestinal flora. We previously found that phytosterol esters (PSEs) could effectively prevent the progression of NAFLD. Here, we further investigated the regulatory effect that PSEs have on gut flora and faecal metabolites in rats with NAFLD. Adult SD (Sprague Dawley) rats were randomized into four groups: the normal chow diet (NC), high-fat diet (HFD), low-dose PSE (0.05 g per 100 g BW, PSEL) and high-dose PSE (0.10 g per 100 g BW, PSEH) groups. PSEs were intragastrically administered once a day for 12 consecutive weeks. Our work indicated that high-dose PSE treatment effectively inhibited the increase in liver and abdominal fat indexes (P < 0.01) and hepatic lipids (P < 0.01); a high dose PSE treatment effectively corrected the HFD-induced intestinal flora imbalance by changing the diversity. The relative abundances of the four phyla (Firmicutes, Proteobacteria, Actinobacteria and Verrucomicrobia) and partial bacteria at the genus level (Faecalibacterium, Akkermansia, etc.) in the PSEH group were closer to those in the NC group. High-dose PSE intervention significantly increased the relative abundance of Bacteroidetes and Anaerostipes. Compared with the HFD, PSEH treatment significantly decreased the ionic strengths of bile acid metabolism products (P < 0.05), which were positively correlated with hepatic steatosis. In conclusion, PSE treatment exerts a beneficial effect on NAFLD that is associated with its regulatory action on intestinal flora and faecal metabolites, which might present a new opportunity to develop effective and safe preventive strategies against NAFLD.Keywords
Funding Information
- BASF (SA 1500053)
- National Natural Science Foundation of China (81472770, 81672350, 81872225)
This publication has 35 references indexed in Scilit:
- Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic MicePLOS ONE, 2013
- High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling PathwayPLOS ONE, 2012
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseProceedings of the National Academy of Sciences, 2011
- Intestinal microbiota in human health and disease: the impact of probioticsGenes & Nutrition, 2011
- Bile acids: regulation of synthesisJournal of Lipid Research, 2009
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†Hepatology, 2009
- Symbiotic gut microbes modulate human metabolic phenotypesProceedings of the National Academy of Sciences, 2008
- Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseJournal of Clinical Investigation, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006